Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease

The aim of this study was to explore concentrations differences of soluble amyloid precursor protein (sAPP) α and β in blood plasma in patients with probable Alzheimer's disease (AD) and cognitively healthy age-matched control subjects, as well as patients with behavioural variant frontotempora...

Descripción completa

Detalles Bibliográficos
Autores principales: Perneczky, R, Guo, L-H, Kagerbauer, S M, Werle, L, Kurz, A, Martin, J, Alexopoulos, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591004/
https://www.ncbi.nlm.nih.gov/pubmed/23423136
http://dx.doi.org/10.1038/tp.2013.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591004/
https://www.ncbi.nlm.nih.gov/pubmed/23423136
http://dx.doi.org/10.1038/tp.2013.11

Ejemplares similares